51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-194761	23/5/2019	17/05/2019	A Phase 3 study of KHK4827 in patients with systemic sclerosis	A Phase 3, placebo-controlled, double-blind comparative study of KHK4827 with an open-label extension period in subjects with systemic sclerosis who have moderate to severe skin thickening	Systemic sclerosis	Intervention name : KHK4827 INN of the intervention : Brodalumab Dosage And administration of the intervention : 210 mg Q2W, SC Control intervention name : Placebo INN of the control intervention : - Dosage And administration of the control intervention : 210 mg Q2W, SC	Kyowa Kirin Co., Ltd.	NULL	complete	18	70	BOTH	100	Phase 3	Japan
2	JPRN-JapicCTI-173686	06/10/2017	29/08/2017	A Phase 1, open-label, multiple-dose study of KHK4827 in subjects with systemic sclerosis	A Phase 1, open-label, multiple-dose study of KHK4827 in subjects with systemic sclerosis	systemic sclerosis	Intervention name : KHK4827 INN of the intervention : brodalumab Dosage And administration of the intervention : SC, 210 mg Q2W Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : -	Kyowa Kirin Co., Ltd.	NULL	complete	18	70	BOTH	6	Phase 1	Japan